ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.365,20
1,06%
S&P 500
5.188,19
0,14%
Dow Jones
38.949,02
0,25%
Euro vs US Dollar
1,07827
0,14%
Bitcoin
63.325,05
0,25%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)

  7. Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ) News

APCVZ

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:APCVZ
DatumZeitQuelleÜberschriftSymbolFirma
07/03/201120h58Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist & Deregister Contingent Value Rights for APP Pharmaceuti...NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
23/02/201112h04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
23/02/201112h04Edgar (US Regulatory)Annual Report (10-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
23/02/201107h01Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
26/01/201114h00Business WireAPP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
30/11/201007h01Business WireAPP Pharmaceuticals Announces Approval and Launch of Topotecan for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
05/11/201020h39Business WireAPP Pharmaceuticals to Launch Drug HotlineNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/11/201011h04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/11/201001h16Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
30/10/201000h53Business WireAPP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
03/08/201001h15Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/08/201023h16Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
27/07/201019h14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/07/201007h01Business WireAPP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
29/06/201020h44Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
29/06/201007h01Business WireAPP Pharmaceuticals to Market Anastrozole Tablets in the U.S.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
22/06/201007h01Business WireAPP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
21/06/201007h01Business WireAPP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
11/06/201007h01Business WireAPP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
08/06/201007h01Business WireAPP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
10/05/201012h07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
04/05/201012h04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
04/05/201000h41Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
01/04/201017h39Business WireFresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventisNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
31/03/201023h27Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
25/03/201014h15GlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on Fresenius Kabi Pharmaceuticals Holding, Inc.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
23/03/201006h01Business WireAPP Pharmaceuticals Receives Approval for Indomethacin for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
25/02/201021h43Edgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
24/02/201012h03Edgar (US Regulatory)Annual Report (10-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
24/02/201002h08Business WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-KNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
 Showing the most relevant articles for your search:NASDAQ:APCVZ

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
TG
432
Arbor Metals
TG
TUI1
Tui
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
TG
DTE
Deutsche Telekom
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
DBI
MDAX
MDAX
CCOM
US100
US Tech 100
FX
EURJPY
Euro vs Yen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten